Roche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy Written By Ruchika Sharma5 Jun 2025 2:00 PM ISTBasel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to include a new,...
Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL Written By Ruchika Sharma5 Jun 2025 12:24 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that it has entered into a definitive agreement with Agenus Inc. to acquire India and Sri...
Takeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin Lymphoma Written By Ruchika Sharma5 Jun 2025 11:30 AM ISTOsaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with etoposide,...
CDSCO Panel Seeks Revised Protocol for Green Signal's BCG Vaccine PMS Study Written By Dr. Kamal Kant Kohli5 Jun 2025 10:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) on Vaccines, operating under the Central Drugs Standard Control Organization (CDSCO), has reviewed the...
Cancer drug: Dr Reddy's Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda Written By Ruchika Sharma5 Jun 2025 10:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd. and Alvotech, a global biotech company specializing in the development and manufacture of...
Haleon appoints Sachin Bhatnagar as VP - Head of Procurement EMEA Ruchika Sharma4 Jun 2025 5:50 PM ISTHaleon has named Sachin Bhatnagar as Vice President - Head of Procurement EMEA.Sachin Bhatnagar shared the update via LinkedIn, stating, "I’m...
CDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant Women Written By Dr. Kamal Kant Kohli4 Jun 2025 3:33 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Vaccines under the Central Drugs Standard Control Organisation (CDSCO) has recommended the conduct...
MSN Labs Gets SEC Nod to Conduct Phase III Trial of Semaglutide Written By Dr. Divya Colin4 Jun 2025 3:10 PM ISTNew Delhi: Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee (SEC) functional...
Revise Phase IV Protocol for Gliclazide-Sitagliptin FDC with Scientific Justification: SEC Tells Eris Written By Dr. Divya Colin4 Jun 2025 3:01 PM ISTNew Delhi: Reviewing the Phase IV clinical trial of Eris Lifesciences' Fixed Dose Combination (FDC) antidiabetic drug Gliclazide plus Sitagliptin, the...
Bayer Prostate Cancer Drug Nubeqa gains third regulatory win from USFDA Written By Ruchika Sharma4 Jun 2025 2:59 PM ISTBerlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for its oral androgen receptor inhibitor (ARi) Nubeqa...
Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK Written By Ruchika Sharma4 Jun 2025 2:29 PM ISTMumbai: Indoco Remedies has announced that its subsidiary company, Indoco Remedies UK Limited, has officially launched Ticagrelor film-coated...
Sanofi Rilzabrutinib gets USFDA orphan drug designation for sickle cell disease Written By Ruchika Sharma4 Jun 2025 1:30 PM ISTParis: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, advanced, oral,...
